AC
XERS icon

Armistice Capital’s Xeris Biopharma Holdings XERS Stock Holding History

Armistice Capital’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Buy
1,958,702
+48,864
+3% +$312K 0.19% 78
2026
Q1 		$11.1M Buy
+1,909,838
New +$12.7M 0.2% 86
2022
Q4 		– Sell
-2,504,431
Closed -$3.91M – 239
2022
Q3 		$3.91M Sell
2,504,431
-3,319,569
-57% -$5.49M 0.07% 106
2022
Q2 		$8.97M Sell
5,824,000
-1,640,993
-22% -$3.46M 0.16% 83
2022
Q1 		$19.1M Buy
+7,464,993
New +$18.2M 0.37% 59

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Armistice Capital's XERS Position: Q2 2026 in Review

Armistice Capital increased its Xeris Biopharma Holdings (XERS) stake by 2.6% in Q2 2026, buying an estimated $312K and bringing the position to 1,958,702 shares worth $15.5M. The position accounts for 0.19% of the portfolio, ranked #78.

Armistice Capital first reported a position in XERS in Q1 2022 and has held it in 5 quarters since. The position peaked at $19.1M in Q1 2022. 239 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Armistice Capital held 1,958,702 shares of Xeris Biopharma Holdings worth $15.5M as of Q2 2026.
  • Armistice Capital bought 48,864 Xeris Biopharma Holdings shares in Q2 2026, an estimated $312K.
  • Xeris Biopharma Holdings made up 0.19% of Armistice Capital's portfolio in Q2 2026, its #78 holding.
  • Armistice Capital first reported a position in Xeris Biopharma Holdings in Q1 2022 and has held it in 5 quarters since.
  • Armistice Capital's Xeris Biopharma Holdings position peaked at $19.1M in Q1 2022.
  • 239 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.